Well done to Vlad15 Nov 2023 08:33
I previously have been sceptical and had my voews on where the SP will go, but here you now have a business definately in the ascendence, and you have to hand it to Vlad and his team. To go clinical is a major achievement, and now the genie is out the bottle, my view is most certainly the m cap is way, way, undervalued. Previously there were too many ifs buts and maybes. GL.
AIMO.